<p>Pharmacological therapy is the core of IBD treatment, mainly including the following categories: aminosalicylic acid, glucocorticoids, immunosuppressants, biologics, antibiotics, probiotics, anticholinergics, etc. These drugs are usually immunosuppressive and increase the risk of infection with long-term use; Special targeted drugs have the disadvantage of being expensive.</p>
<h4>Nutritional Therapies</h4>
<p>Nutritional therapy plays an important role in the remission and prognosis of IBD. However, at present, nutritional therapy is faced with problems such as slow effect, long course of treatment, and insufficient targeting, which will affect the quality of life of patients.</p>
<p>Our components have been designed to integrate muscone induction and the therapeutic capabilities of lactate. These parts embody our collective effort and wisdom, enabling us to achieve success in the laboratory work of our project.</p>
